Shipman & Goodwin’s Life Sciences practice includes the representation of companies engaged in biopharmaceuticals, biotechnology, diagnostics, drug delivery, genomics, healthcare informatics, healthcare services, medical devices, nanotechnology, pharmaceuticals, therapeutics and vaccines and the representation of financial and strategic investors investing in life science companies. Our counsel includes matters related to formation, governance, intellectual property, technology and trademark protection and commercialization, equity and debt financings, research and development and collaboration arrangements, strategic alliances and joint ventures, spin-outs, acquisitions and dispositions, government and philanthropic grant arrangements, executive compensation and equity incentive plans and regulatory counseling and compliance. Because our attorneys have backgrounds in business, finance, healthcare, science and technology, we understand the issues facing our clients in the life sciences industry and we have a unique combination of deep experience, superior industry knowledge, business savvy and legal acumen to help our clients achieve their goals. Dormer Stephen, Co-Chair of our Business and Finance Practice Group, is a trusted advisor to leading and sophisticated companies and investors in the life sciences industry. Here are some of the investors and life science companies that Dormer has worked with.

J. Dormer Stephen(203) 836-2803dstephen@goodwin.com